Skip to main content

Peer Review reports

From: A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Original Submission
27 May 2011 Submitted Original manuscript
14 Jul 2011 Reviewed Reviewer Report - Alberto Parabiaghi
10 Aug 2011 Reviewed Reviewer Report - David Kemp
10 Oct 2011 Author responded Author comments - Danielle Coppola
Resubmission - Version 2
10 Oct 2011 Submitted Manuscript version 2
9 Nov 2011 Reviewed Reviewer Report - David Kemp
14 Nov 2011 Reviewed Reviewer Report - Alberto Parabiaghi
22 Dec 2011 Author responded Author comments - Danielle Coppola
Resubmission - Version 3
22 Dec 2011 Submitted Manuscript version 3
9 Jan 2012 Reviewed Reviewer Report - Alberto Parabiaghi
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2012 Editorially accepted
28 Mar 2012 Article published 10.1186/1471-244X-12-26

You can find further information about peer review here.

Back to article page